Jeffrey E. Russel

Array ( [id] => 7728644 [patent_doc_number] => 08101202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Gentle process for conversion of cystine in keratin-containing materials to lanthionine' [patent_app_type] => utility [patent_app_number] => 11/570402 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2269 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101202.pdf [firstpage_image] =>[orig_patent_app_number] => 11570402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639129 [patent_doc_number] => 08017156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => 'Long-acting colloidal insulin formulation and its preparation' [patent_app_type] => utility [patent_app_number] => 11/632992 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7240 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017156.pdf [firstpage_image] =>[orig_patent_app_number] => 11632992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952829 [patent_doc_number] => 20050227924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Peyer\'s patch and/or M-cell targeting ligands' [patent_app_type] => utility [patent_app_number] => 11/147083 [patent_app_country] => US [patent_app_date] => 2005-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 12953 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227924.pdf [firstpage_image] =>[orig_patent_app_number] => 11147083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614419 [patent_doc_number] => 20060116347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Methods and compositions to treat glycosaminoglycan-associated molecular interactions' [patent_app_type] => utility [patent_app_number] => 11/147150 [patent_app_country] => US [patent_app_date] => 2005-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 15269 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116347.pdf [firstpage_image] =>[orig_patent_app_number] => 11147150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6967071 [patent_doc_number] => 20050233968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Polyamino acid-based insulin preparation' [patent_app_type] => utility [patent_app_number] => 11/145208 [patent_app_country] => US [patent_app_date] => 2005-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4239 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233968.pdf [firstpage_image] =>[orig_patent_app_number] => 11145208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126440 [patent_doc_number] => 20070238711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Combination Therapy with Glatiramer Acetate and Minocycline for the Treatment of Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 11/597571 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9547 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238711.pdf [firstpage_image] =>[orig_patent_app_number] => 11597571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23879 [patent_doc_number] => 07795223 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Treatment of inflammatory airway disease' [patent_app_type] => utility [patent_app_number] => 11/597320 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17946 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795223.pdf [firstpage_image] =>[orig_patent_app_number] => 11597320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250415 [patent_doc_number] => 20050272703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Anti-tumor agents' [patent_app_type] => utility [patent_app_number] => 11/131478 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17770 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272703.pdf [firstpage_image] =>[orig_patent_app_number] => 11131478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914496 [patent_doc_number] => 07326683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions' [patent_app_type] => utility [patent_app_number] => 11/124490 [patent_app_country] => US [patent_app_date] => 2005-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16108 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326683.pdf [firstpage_image] =>[orig_patent_app_number] => 11124490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569132 [patent_doc_number] => 07462597 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Corticotropin releasing factor 2 receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/121612 [patent_app_country] => US [patent_app_date] => 2005-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21239 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462597.pdf [firstpage_image] =>[orig_patent_app_number] => 11121612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758825 [patent_doc_number] => 20080311051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Caspase-2 Inhibitors And Their Biological Applications' [patent_app_type] => utility [patent_app_number] => 11/579202 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10545 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311051.pdf [firstpage_image] =>[orig_patent_app_number] => 11579202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748368 [patent_doc_number] => 20060111300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone' [patent_app_type] => utility [patent_app_number] => 11/121166 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5608 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111300.pdf [firstpage_image] =>[orig_patent_app_number] => 11121166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 167773 [patent_doc_number] => RE041133 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-02-16 [patent_title] => 'Glucagon-like peptide-1 crystals' [patent_app_type] => reissue [patent_app_number] => 11/119500 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8234 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041133.pdf [firstpage_image] =>[orig_patent_app_number] => 11119500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964795 [patent_doc_number] => 09012407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Therapies which act on neuropeptide S receptors' [patent_app_type] => utility [patent_app_number] => 11/587444 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 53 [patent_no_of_words] => 13629 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11587444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7244244 [patent_doc_number] => 20050271722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Sustained release formulations' [patent_app_type] => utility [patent_app_number] => 11/114473 [patent_app_country] => US [patent_app_date] => 2005-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5371 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271722.pdf [firstpage_image] =>[orig_patent_app_number] => 11114473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693081 [patent_doc_number] => 20080085852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Use of Xikvav Peptides in the Preparation of Cosmetic Compositions Which are Intented to Improve the Firmness of the Skin by Increasing Cell Adhesion' [patent_app_type] => utility [patent_app_number] => 11/587878 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3170 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085852.pdf [firstpage_image] =>[orig_patent_app_number] => 11587878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912364 [patent_doc_number] => 20050176122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Isolation of proteins' [patent_app_type] => utility [patent_app_number] => 11/098391 [patent_app_country] => US [patent_app_date] => 2005-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23425 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176122.pdf [firstpage_image] =>[orig_patent_app_number] => 11098391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42796 [patent_doc_number] => 07781406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Production and use of the methotrexate-albumin conjugate as an immunosuppressive agent in GVHD' [patent_app_type] => utility [patent_app_number] => 10/594876 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3781 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781406.pdf [firstpage_image] =>[orig_patent_app_number] => 10594876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955397 [patent_doc_number] => 20080188421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Hunter-Killer Peptides and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/795703 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17259 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188421.pdf [firstpage_image] =>[orig_patent_app_number] => 11795703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202676 [patent_doc_number] => 07632811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Analogs of parathyroid hormone' [patent_app_type] => utility [patent_app_number] => 11/094662 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16212 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632811.pdf [firstpage_image] =>[orig_patent_app_number] => 11094662 [rel_patent_id] =>[rel_patent_doc_number] =>)